You are here

Christian Dillon

Associate Director, Target Validation & Disease Positioning

Since joining CRUK-TDL (then CRT-DL) in 2005, Christian has led a broad range of projects from early target identification and validation through to lead optimisation. A cell biologist by training, Christian has experience in leading cross-functional project teams and has overseen a multi-project alliance on the DNA Damage Response with Teva Pharmaceuticals. Christian has a strong interest in reducing novel target attrition rates within early stage drug discovery. Christian obtained his first degree in Biology from Imperial College, received his PhD from University College London in 2002 and went on to complete his postdoctoral research at the Medical Research Council Laboratory for Molecular Cell Biology.